IP Library Granted Patent US 8,268,343
Granted Patent B2
US 8,268,343 · App. 12/417,963 · Granted Sep 18, 2012

Non-hormonal vaginal contraceptive

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,268,343
App. No.
12/417,963
Granted
Sep 18, 2012
Kind
B2
Abstract

The present invention relates to a non-hormonal, biocompatible, and biodegradable intravaginal device for the delivery of spermiostatic, spermicidal and anti-infectious agents. The present invention also relates to methods of contraception using such a device, as well as the prevention and treatment of sexually transmitted diseases and vaginal infections through the application of the device.

Claims (39)

1. An intravaginal contraceptive device, comprising:

a biocompatible polymeric support structure configured to be inserted into a woman's vagina, the support structure constructed, configured and formed of materials such that the structure is capable of biocompatibly remaining in a woman's vagina for three days without dissolving completely;

the support structure impregnated with a non-hormonal composition comprising ascorbic acid in an effective amount to increase the viscosity of cervical mucus and a contraceptively effective amount of ferrous gluconate or ferrous-sulfate, the device configured and formed with biodegradable materials so that when inserted into the vagina the ascorbic acid and ferrous gluconate or ferrous sulfate are released via degradation of the biodegradable materials of the device, to contraceptively reduces sperm mobility and contraceptively increases cervical mucus to impeded sperm mobility and the device includes a releasable pH limiting component to maintain a pH in the vaginal cavity at a spermiostatic level;

the support structure with the composition disposed therein constructed and formed with materials effective to break down when present within the vagina and provide sustained release of a contraceptively effective amount of the composition for three days.

2. The device of claim 1 , wherein the non-hormonal composition is effective to maintain the pH in the vaginal cavity at about 5.

3. The device of claim 1 , wherein the composition comprises ferrous gluconate.

4. The device of claim 1 , wherein the composition comprises ferrous sulfate.

5. An intravaginal contraceptive device, comprising:

a biocompatible polymeric support structure configured to be inserted into a woman's vagina, the support structure constructed, configured and formed of materials such that the structure is capable of biocompatibly remaining in a woman's vagina for 28 days without dissolving completely;

the support structure impregnated with a non-hormonal composition comprising ascorbic acid in an effective amount to increase the viscosity of cervical mucus and a contraceptively effective amount of ferrous gluconate or ferrous sulfate, the device configured and formed with biodegradable materials so that when inserted into the vagina, the ascorbic acid and ferrous gluconate or ferrous sulfate are released via degradation of the biodegradable materials of the device, to contraceptively reduces sperm mobility and contraceptively increases cervical mucus to impeded sperm mobility and the device includes a releasable pH limiting component to maintain a pH n the vaginal cavity at a spermiostatic level;

the support structure with the composition disposed therein constructed and formed with materials effective to break down when present within the vagina and provide sustained release of a contraceptively effective amount of the composition for 28 days.

6. The device of claim 1 , wherein the composition further comprises magnesium chloride or calcium chloride.

7. The device of claim 1 , wherein the support structure comprises poly-DL lactide.

8. The device of claim 1 , wherein the support structure has an opening therethrough and said composition comprises a spermicidally or spermiostatically effective amount of an acid-rich polymer.

9. The device of claim 8 , wherein the support structure comprises hydrogel material.

10. The device of claim 8 , wherein the composition comprises ferrous gluconate.

11. The device of claim 6 , wherein the support structure comprises hydrogel material.

12. The device of claim 8 , wherein the acid-rich polymer comprises a polyamino acid, a polycarboxylic acid, or combinations thereof.

13. The device of claim 1 , wherein the support structure has an annular shape.

14. The device of claim 13 , wherein the pH limiting component is present in an effective amount to prevent the pH in a vagina from increasing in the presence of seminal fluid.

15. The device of claim 13 , wherein the composition comprises a biocompatible organic acid.

16. The device of claim 13 , wherein the composition comprises a polyamino acid or a polycarboxylic acid or combinations thereof.

17. The device of claim 16 , wherein the device is in a ring-like configuration.

18. The device of claim 16 , wherein the support structure comprises a convoluted shape.

19. An intravaginal contraceptive device, comprising:

a biocompatible polymeric support structure configured to be inserted into a woman's vagina, the support structure constructed, configured and formed of materials such that the structure is capable of biocompatibly remaining in a woman's vagina for 7 days without dissolving completely;

the support structure impregnated with a non-hormonal composition comprising ascorbic acid in an effective amount to increase the viscosity of cervical mucus and a contraceptively effective amount of ferrous gluconate or ferrous sulfate, the device configured and formed with biodegradable materials so that when inserted into the vagina, the ascorbic acid and ferrous gluconate or ferrous sulfate are released via degradation of the biodegradable materials of the device, to contraceptively reduces sperm mobility and contraceptively increases cervical mucus to impeded sperm mobility and the device including a releasable pH limiting component to maintain a pH in the vaginal cavity at a spermiostatic level;

the support structure with the composition disposed therein is constructed and formed of materials effective to provide sustained release of said effective amount of the composition for 7 days.

20. An intravaginal contraceptive device, comprising:

a biocompatible polymeric support structure configured to be inserted into a woman's vagina, the support structure constructed, configured and formed of materials such that the structure is capable of biocompatibly remaining in a woman's vagina for 16 days without dissolving completely;

the support structure impregnated with a non-hormonal composition comprising ascorbic acid in an effective amount to increase the viscosity of cervical mucus and a contraceptively effective amount of ferrous gluconate or ferrous sulfate, the device configured and formed with biodegradable materials so that when inserted into the vagina, the ascorbic acid and ferrous gluconate or ferrous sulfate are released via degradation of the biodegradable materials of the device, to contraceptively reduce sperm mobility and contraceptively increases cervical mucus to impeded sperm mobility and the device including a releasable pH limiting component to maintain a pH in the vaginal cavity at a spermiostatic level;

the support structure with composition disposed therein is constructed and formed of materials effective to provide sustained release of said effective amount of the composition for 16 days.

21. The device of claim 1 , wherein the device comprises effective amounts of the pH limiting component to maintain a pH of about 5-6 in a vagina during the sustained release of said composition, in the presence of semenal fluid.

22. The device of claim 13 , wherein the composition comprises ferrous gluconate.

23. The device of claim 1 , wherein the support structure comprises hydrogel material.

24. The device of claim 1 , wherein the support structure comprises at least one of dextran-maleic acid, dextran-acrylate, dextran-allyl isocyanate, polyglycolide, polylactide, co-polymers of polyglycolide or polylactide, or combinations thereof.

25. The device of claim 1 , wherein the support structure comprises a plurality of layered polymer sheaths over a core.

26. The device of claim 1 , wherein the support structure comprises a plurality of layered polymer sheaths that dissolve at varying rates.

27. The device of claim 1 , wherein the device is effective to result in producing a pH of about 3.5 to 5.5.

Continuity (3)
Continuation 10362068
Provisional Application 60227740 · Aug 24, 2000
Related Publication 20090246254A1 · Oct 1, 2009